• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动的命名、定义及机制:信号峰会国际工作组立场文件

Atrial fibrillation nomenclature, definitions, and mechanisms: Position paper from the international Working Group of the Signal Summit.

作者信息

de Groot Natasja M S, Kleber Andre, Narayan Sanjiv M, Ciaccio Edward J, Doessel Olaf, Bernus Olivier, Berenfeld Omer, Callans David, Fedorov Vadim, Hummel John, Haissaguerre Michel, Natale Andrea, Trayanova Natalia, Spector Peter, Vigmond Edward, Anter Elad

机构信息

Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Boston, Massachusetts, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

出版信息

Heart Rhythm. 2024 Nov 17. doi: 10.1016/j.hrthm.2024.11.012.

DOI:
10.1016/j.hrthm.2024.11.012
PMID:39561931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12084426/
Abstract

The international Working Group of the Signal Summit is a consortium of experts in the field of cardiac electrophysiology dedicated to advancing knowledge on understanding and clinical application of signal recording and processing techniques. In 2023, the working group met in Reykjavik, Iceland, and laid the foundation for this manuscript. Atrial fibrillation (AF) is the most common arrhythmia in adults, with a rapidly increasing prevalence worldwide. Despite substantial research efforts, advancements in elucidating the underlying mechanisms of AF have been relatively modest. Since the discovery of pulmonary veins as a frequent trigger region for AF initiation more than 2½ decades ago, advancements in patient care have primarily focused on technologic innovations to improve the safety and efficacy of pulmonary vein isolation (PVI). Several factors may explain the limited scientific progress made. First, whereas AF initiation usually begins with an ectopic beat, the mechanisms of initiation, maintenance, and electrical propagation have not been fully elucidated in humans, largely owing to suboptimal spatiotemporal mapping. Second, underlying structural changes have not been clarified and may involve different types of reentry. Third, inconsistent definitions and terminology regarding fibrillatory characteristics contribute to the challenges of comparing results between studies. Fourth, a growing appreciation for phenotypical differences probably explains the wide range of clinical outcomes to catheter ablation in patients with seemingly similar AF types. Last, restoring sinus rhythm in advanced phenotypic forms of AF is often not feasible or may require extensive ablation with minimal or no positive impact on quality of life. The aims of this international position paper are to provide practical definitions as a foundation for discussing potential mechanisms and mapping results and to propose pathways toward meaningful advancements in AF research, ultimately leading to improved therapies for AF.

摘要

信号峰会国际工作组是心脏电生理学领域的专家联盟,致力于推动信号记录与处理技术在理解和临床应用方面的知识进步。2023年,该工作组在冰岛雷克雅未克召开会议,为本文奠定了基础。心房颤动(AF)是成年人中最常见的心律失常,在全球范围内其患病率正在迅速上升。尽管进行了大量研究,但在阐明房颤潜在机制方面取得的进展相对有限。自二十多年半前发现肺静脉是房颤起始的常见触发区域以来,患者护理方面的进展主要集中在技术创新上,以提高肺静脉隔离(PVI)的安全性和有效性。有几个因素可以解释所取得的科学进展有限的原因。首先,虽然房颤通常始于异位搏动,但在人类中,起始、维持和电传导的机制尚未完全阐明,这主要是由于时空映射不理想。其次,潜在的结构变化尚未明确,可能涉及不同类型的折返。第三,关于颤动特征的定义和术语不一致,给比较不同研究结果带来了挑战。第四,对表型差异的认识不断提高,这可能解释了在看似相似的房颤类型患者中,导管消融临床结果差异很大的原因。最后,在晚期表型房颤中恢复窦性心律通常不可行,或者可能需要广泛消融,而对生活质量的积极影响很小或没有。本国际立场文件的目的是提供实用定义,作为讨论潜在机制和映射结果的基础,并提出房颤研究取得有意义进展的途径,最终实现房颤治疗的改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9c/12084426/939f262ee13a/nihms-2048671-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9c/12084426/2fc695da8114/nihms-2048671-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9c/12084426/edad0e6d5119/nihms-2048671-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9c/12084426/939f262ee13a/nihms-2048671-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9c/12084426/2fc695da8114/nihms-2048671-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9c/12084426/edad0e6d5119/nihms-2048671-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd9c/12084426/939f262ee13a/nihms-2048671-f0003.jpg

相似文献

1
Atrial fibrillation nomenclature, definitions, and mechanisms: Position paper from the international Working Group of the Signal Summit.心房颤动的命名、定义及机制:信号峰会国际工作组立场文件
Heart Rhythm. 2024 Nov 17. doi: 10.1016/j.hrthm.2024.11.012.
2
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Mechanistic Insights From Trials of Atrial Fibrillation Ablation: Charting a Course for the Future.从房颤消融试验中获得的机制见解:为未来规划路线。
Circ Arrhythm Electrophysiol. 2024 Aug;17(8):e012939. doi: 10.1161/CIRCEP.124.012939. Epub 2024 Jul 23.
5
Catheter ablation for paroxysmal and persistent atrial fibrillation.阵发性和持续性心房颤动的导管消融术
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD007101. doi: 10.1002/14651858.CD007101.pub2.
6
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
7
External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.体外电复律和药物复律治疗心房颤动、心房扑动或房性心动过速的网状 Meta 分析。
Cochrane Database Syst Rev. 2024 Jun 3;6(6):CD013255. doi: 10.1002/14651858.CD013255.pub2.
8
Pulmonary Vein Isolation With Optimized Linear Ablation vs Pulmonary Vein Isolation Alone for Persistent AF: The PROMPT-AF Randomized Clinical Trial.优化线性消融与单纯肺静脉隔离治疗持续性房颤的对比:PROMPT-AF随机临床试验
JAMA. 2025 Feb 4;333(5):381-389. doi: 10.1001/jama.2024.24438.
9
Short-Term Memory Impairment短期记忆障碍
10
AF-FLOW Global Registry Confirms Validity of Electrographic Flow Mapping as a Phenotyping Tool for Atrial Fibrillation.AF-FLOW全球注册研究证实电描记血流图作为心房颤动表型分析工具的有效性。
J Cardiovasc Electrophysiol. 2025 Mar;36(3):589-599. doi: 10.1111/jce.16568. Epub 2025 Jan 16.

引用本文的文献

1
IL-11 promotes Ang II-induced autophagy inhibition and mitochondrial dysfunction in atrial fibroblasts.白细胞介素-11促进血管紧张素II诱导的心房成纤维细胞自噬抑制和线粒体功能障碍。
Open Life Sci. 2025 Mar 11;20(1):20251063. doi: 10.1515/biol-2025-1063. eCollection 2025.
2
Advancing Atrial Fibrillation Research: The Role of Animal Models, Emerging Technologies and Translational Challenges.推进心房颤动研究:动物模型、新兴技术及转化挑战的作用
Biomedicines. 2025 Jan 27;13(2):307. doi: 10.3390/biomedicines13020307.

本文引用的文献

1
Effects of Glucagon-Like Peptide 1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-analysis.胰高血糖素样肽-1 受体激动剂对导管消融后心房颤动复发的影响:系统评价和荟萃分析。
Adv Ther. 2024 Oct;41(10):3749-3756. doi: 10.1007/s12325-024-02959-x. Epub 2024 Aug 14.
2
Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial.口吸入氟卡尼治疗心房颤动转为窦性节律:INSTANT 阶段 2 试验。
JACC Clin Electrophysiol. 2024 Jun;10(6):1021-1033. doi: 10.1016/j.jacep.2024.02.021. Epub 2024 Apr 10.
3
Glucagon-Like Peptide-1 Protects Against Atrial Fibrillation and Atrial Remodeling in Type 2 Diabetic Mice.
胰高血糖素样肽-1对2型糖尿病小鼠的心房颤动和心房重构具有保护作用。
JACC Basic Transl Sci. 2023 Mar 15;8(8):922-936. doi: 10.1016/j.jacbts.2023.01.005. eCollection 2023 Aug.
4
Temporal Trends and Lesion Sets for Persistent Atrial Fibrillation Ablation: A Meta-Analysis With Trial Sequential Analysis and Meta-Regression.持续性心房颤动消融的时间趋势和病变集:一项采用试验序贯分析和荟萃回归的荟萃分析。
Circ Arrhythm Electrophysiol. 2023 Sep;16(9):e011861. doi: 10.1161/CIRCEP.123.011861. Epub 2023 Aug 17.
5
A computational modeling framework for pre-clinical evaluation of cardiac mapping systems.一种用于心脏标测系统临床前评估的计算建模框架。
Front Physiol. 2023 Jul 6;14:1074527. doi: 10.3389/fphys.2023.1074527. eCollection 2023.
6
Insights Into the Effects of Low-Level Vagus Nerve Stimulation on Atrial Electrophysiology: Towards Patient-Tailored Cardiac Neuromodulation.深入探讨低水平迷走神经刺激对心房电生理的影响:迈向个体化心脏神经调节。
JACC Clin Electrophysiol. 2023 Sep;9(9):1843-1853. doi: 10.1016/j.jacep.2023.05.011. Epub 2023 Jul 19.
7
Phenotyping of atrial fibrillation with cluster analysis and external validation.采用聚类分析和外部验证进行心房颤动表型分析。
Heart. 2023 Nov 10;109(23):1751-1758. doi: 10.1136/heartjnl-2023-322447.
8
Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial.脉冲场消融治疗心房颤动:PULSED AF 关键试验。
Circulation. 2023 May 9;147(19):1422-1432. doi: 10.1161/CIRCULATIONAHA.123.063988. Epub 2023 Mar 6.
9
Atrial fibrillation: Insights from animal models, computational modeling, and clinical studies.心房颤动:动物模型、计算建模和临床研究的新见解。
EBioMedicine. 2022 Nov;85:104310. doi: 10.1016/j.ebiom.2022.104310. Epub 2022 Oct 26.
10
Personalized ablation vs. conventional ablation strategies to terminate atrial fibrillation and prevent recurrence.个体化消融与常规消融策略终止心房颤动并预防复发的比较。
Europace. 2023 Feb 8;25(1):211-222. doi: 10.1093/europace/euac116.